While it is true that the CBD Life Sciences (OTCMKTS:CBDL) stock was trading in a range on Thursday, it should be noted that there was important news about the company yesterday and that is something that investors could look into.
Trading Data
On Thursday, CBDL stock ended flat at $0.0002 with more than 238.56 million shares, compared to its average volume of 173.57 million shares. The stock moved within a range of $0.0001 – 0.0003 after opening trade at $0.0002.
CBD Life Sciences, Inc. (CBDL) Announces Launch of Vegan Gummies on Amazon Platform
CBD Life Sciences announced yesterday that through its fully owned subsidiary company LBO Biosciences Inc, it was going to launch its product, the 300 MG Vegan Gummies on Amazon. In this regard, it ought to be noted that it is one of the top selling products from CBD Life Sciences and the launch on Amazon is also important. Amazon is the biggest e-commerce platform in the United States and is expected to open up a vast pool of customers.
The lunch if going to happen at the end of this week and it is something that investors are possibly going to be watching closely. In this context, it ought to be noted that the launch of Amazon is going to be the fruition of the company’s efforts to launch its product offerings on the e-commerce website. CBD Life Sciences has worked hard towards this goal over the course of the past months.
Key Quote
President & CEO Lisa Nelson states “We want to give the customers more of an option when it comes to taking CBD and this is the perfect step in the right direction to provide Vegans with the most top shelf gummies on the market!” Lisa Nelson also states “Our Vegan gummies do not contain any toxins that ensure long shelf life. They are also eco-friendly and use naturally available materials to grow the hemp plant organically for making the CBD gummies.”
Technical Data
CBDL stock is trading above the 20-Day and 50-Day Moving averages of $0.0002 and $0.0002 respectively. However, the stock is below 200-Day moving average of $0.0004.
